» Articles » PMID: 26088310

Antinuclear Antibodies Are Associated With All-Cause Mortality and Cardiovascular Outcomes in the General Population

Overview
Date 2015 Jun 20
PMID 26088310
Citations 11
Authors
Affiliations
Soon will be listed here.
Citing Articles

Unveiling the threat of crystalline silica on the cardiovascular system. A comprehensive review of the current knowledge.

Gurzu I, Handra C, Ghita I, Otelea M Front Cardiovasc Med. 2025; 12:1506846.

PMID: 40027509 PMC: 11868085. DOI: 10.3389/fcvm.2025.1506846.


Recognition of rare antinuclear antibody patterns based on a novel attention-based enhancement framework.

Zeng J, Gao X, Gao L, Yu Y, Shen L, Pan X Brief Bioinform. 2024; 25(2).

PMID: 38279651 PMC: 10818137. DOI: 10.1093/bib/bbad531.


Clinical diagnoses associated with a positive antinuclear antibody test in patients with and without autoimmune disease.

Zanussi J, Zhao J, Wei W, Karakoc G, Chung C, Feng Q BMC Rheumatol. 2023; 7(1):24.

PMID: 37550754 PMC: 10405518. DOI: 10.1186/s41927-023-00349-4.


Prevalence of Antiphospholipid Antibodies and Association With Incident Cardiovascular Events.

Zuo Y, Navaz S, Liang W, Li C, Ayers C, Rysenga C JAMA Netw Open. 2023; 6(4):e236530.

PMID: 37014642 PMC: 10074226. DOI: 10.1001/jamanetworkopen.2023.6530.


Current Toolset in Predicting Acute Coronary Thrombotic Events: The "Vulnerable Plaque" in a "Vulnerable Patient" Concept.

Emfietzoglou M, Mavrogiannis M, Garcia-Garcia H, Stamatelopoulos K, Kanakakis I, Papafaklis M Life (Basel). 2023; 13(3).

PMID: 36983851 PMC: 10052113. DOI: 10.3390/life13030696.